secwatch.observer — SEC 8-K summary
======================================

Issuer:     Semnur Pharmaceuticals, Inc. (SMNR)
CIK:        0001913577
Form:       8-K
Filed at:   2023-11-20T23:59:59+00:00
Accession:  0001213900-23-088773
Event type: other_material
Sentiment:  neutral
Materiality: 0.45
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Denali SPAC amends PIPE; cuts preferred shares to 1.3M, adds warrants, waives asset condition
--------------------------------------------------------------------------------

- FutureTech Capital reduced preferred stock commitment from 1.8M to 1.3M shares at $10 per share.
- Each preferred share now includes two warrants exercisable at $8.00 for five years starting six months post-closing.
- Underwriters agreed to take $866,250 deferred discount as 86,625 Holdco common shares; $2,021,250 remains cash.
- Parties waived condition requiring Holdco to have net tangible assets of at least $5,000,001 at closing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1913577/000121390023088773/0001213900-23-088773-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1913577/000121390023088773/ea188711-8k425_denalicap.htm
  HTML page:      https://secwatch.observer/filing/0001213900-23-088773

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer